INS and Hypoglycemia: She was started on alpha-blockade therapy with doxazosin at a dose of 2 mg/day as preoperative management. As part of the preoperative preparation, sulfonylureas were discontinued more than two days before surgery and replaced with a basal-bolus insulin regimen to minimize the risk of hypoglycemia and allow for more flexible glycemic control.